Alpha 2.0
Login Register
» Articles » PMID: 1723740

Immunotherapy with Antibodies to Core Lipopolysaccharide: a Critical Appraisal

Overview
Journal Infect Dis Clin North Am
Specialty Infectious Diseases
Date 1991 Dec 1
PMID 1723740
Citations 12
Authors
J D Baumgartner
Affiliations
Soon will be listed here.
Abstract

The unknowns persisting in the understanding of the mode of action of anti-core lipopolysaccharide antibodies are discussed, and a study of two anti-lipid A monoclonal antibodies is reviewed. This article also critically analyzes the results of the recent clinical trials with monoclonal antibodies.

Citing Articles

[Endotoxins. Pathogenetic meaning of sepsis].

Rensing H Anaesthesist. 2004; 52 Suppl 1:S7-S13.

PMID: 14727044 DOI: 10.1007/s00101-003-0587-7.

The economic impact of HA-1A (Centoxin) against endotoxin.

Barriere S Pharmacoeconomics. 1992; 2(5):408-13.

PMID: 10147053 DOI: 10.2165/00019053-199202050-00008.

Fc gamma receptor-dependent clearance is enhanced following lipopolysaccharide in vivo treatment.

Palermo M, Alves Rosa F, Fernandez Alonso G, Isturiz M Immunology. 1998; 92(4):536-43.

PMID: 9497496 PMC: 1364160. DOI: 10.1046/j.1365-2567.1997.00376.x.

Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice.

Bailat S, Heumann D, Le Roy D, Baumgartner J, Rietschel E, Glauser M Infect Immun. 1997; 65(2):811-4.

PMID: 9009348 PMC: 176131. DOI: 10.1128/iai.65.2.811-814.1997.

Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock.

Hoffman W, Danner R, Quezado Z, Banks S, Elin R, Hosseini J Infect Immun. 1996; 64(2):406-12.

PMID: 8550184 PMC: 173778. DOI: 10.1128/iai.64.2.406-412.1996.